Wednesday, October 16, 2024
7:30 PM – 7:45 PM: Registration and Dinner
7:45 PM – 9:15 PM: Symposium
JW Marriott Hotel Los Angeles L.A. LIVE
900 West Olympic Blvd
Los Angeles, CA 90015
Meeting Room: Diamond Ballroom 6-10
PROGRAM FEATURES
-
- Interactive, case-based learning environment
- Downloadable whiteboard animations
- Create your own personalized poster
FACULTY
 |
Charles L. Daley, MD Chief, Division of Mycobacterial and Respiratory Infections National Jewish Health Professor of Medicine University of Colorado Denver and National Jewish Health Denver, CO |
 |
Elisa Ignatius, MD, MSc Assistant Professor of Medicine Divisions of Infectious Diseases and Clinical Pharmacology Johns Hopkins University School of Medicine Baltimore, MD |
PROGRAM OVERVIEW
This live educational activity is designed to meet the educational needs of healthcare providers who have a role in treating patients with nontuberculous mycobacterial lung disease (NTM‐LD), including strategies for overcoming treatment resistance. This activity is designed to increase healthcare providers’ knowledge of treatment approaches and opportunities to implement NTM-LD treatment guidelines in real-world clinical practice. In addition, this program will use a multidisciplinary team (MDT) of specialists and incorporate patient shared decision making (SDM) policies to provide holistic, patient-centered care.
TARGET AUDIENCE
This educational activity is designed to meet the needs of clinicians, particularly pulmonologists and infectious disease (ID) specialists, who have a role in the diagnosis and treatment of patients with NTM‐LD.
LEARNING OBJECTIVES
- Discuss the personalized treatment approaches outlined in the NTM-LD treatment guidelines and the opportunities to further implement these guidelines in real-world clinical practice
- Utilize a multidisciplinary team (MDT) of specialists and incorporate patient shared decision making (SDM) to provide holistic, patient-centered care for individuals with NTM-LD
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.5 ANCC contact hours.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
